- Home
- IMTE vs OGEN Comparison
IMTE vs OGEN Comparison
Compare IMTE & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- OGEN
- Stock Information
- Founded
- IMTE 2008
- OGEN 1996
- Country
- IMTE Malaysia
- OGEN United States
- Employees
- IMTE N/A
- OGEN N/A
- Industry
- IMTE Consumer Electronics/Appliances
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- OGEN Health Care
- Exchange
- IMTE Nasdaq
- OGEN Nasdaq
- Market Cap
- IMTE 4.5M
- OGEN 4.5M
- IPO Year
- IMTE N/A
- OGEN N/A
- Fundamental
- Price
- IMTE $1.21
- OGEN $0.32
- Analyst Decision
- IMTE
- OGEN
- Analyst Count
- IMTE 0
- OGEN 0
- Target Price
- IMTE N/A
- OGEN N/A
- AVG Volume (30 Days)
- IMTE 93.5K
- OGEN 738.8K
- Earning Date
- IMTE 12-27-2024
- OGEN 11-13-2024
- Dividend Yield
- IMTE N/A
- OGEN N/A
- EPS Growth
- IMTE N/A
- OGEN N/A
- EPS
- IMTE N/A
- OGEN N/A
- Revenue
- IMTE $383,813.00
- OGEN N/A
- Revenue This Year
- IMTE N/A
- OGEN N/A
- Revenue Next Year
- IMTE N/A
- OGEN N/A
- P/E Ratio
- IMTE N/A
- OGEN N/A
- Revenue Growth
- IMTE 4.75
- OGEN N/A
- 52 Week Low
- IMTE $1.06
- OGEN $0.28
- 52 Week High
- IMTE $3.84
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- IMTE 41.65
- OGEN 41.16
- Support Level
- IMTE $1.15
- OGEN $0.30
- Resistance Level
- IMTE $1.28
- OGEN $0.43
- Average True Range (ATR)
- IMTE 0.25
- OGEN 0.03
- MACD
- IMTE -0.05
- OGEN 0.01
- Stochastic Oscillator
- IMTE 4.42
- OGEN 23.47
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.